Application
Fluorescent image of U251 cells stained with ATG9A antibody. U251 cells were treated with Chloroquine (50 μM,16h), then fixed with 4% PFA (20 min), permeabilized with Triton X-100 (0.2%, 30 min). Cells were then incubated with AP1814e ATG9A primary antibody (1:100, 2 h at room temperature). For secondary antibody, Alexa Fluor® 488 conjugated donkey anti-rabbit antibody (green) was used (1:1000, 1h). Cytoplasmic actin was counterstained with Alexa Fluor® 555 (red) conjugated Phalloidin (5.25 μM, 25 min). Nuclei were counterstained with Hoechst 33342 (blue) (10 μg/ml, 5 min). Pictures were taken on a Biorevo microscope (BZ-900, Keyence).ATG9A immunoreactivity is localized to autophagic vacuoles in the cytoplasm of U251 cells.Application
"Western blot analysis of APG9L1 (arrow) using rabbit polyclonal APG9L1 Antibody (S613) (Cat.#1814e).293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected with the APG9L1 gene (Lane 2) (Origene Technologies)."Application
Formalin-fixed and paraffin-embedded human lung carcinoma tissue reacted with APG9L1 Antibody (S613) , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Product Name | ATG9A Antibody |
|---|---|
| Antibody Type | Primary Antibodies |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | IFWBIHC |
| IF:1:100 WB |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | APG9L1 |
|---|---|
| Alternative Names | ATG9A APG9L1 Autophagy-related protein 9A APG9-like 1 mATG9 |
| Molecular Weight(MW) | 94447 Da |
| Function | Plays a role in autophagy. Cycles between a juxta- nuclear trans-Golgi network compartment and late endosomes Nutrient starvation induces accumulation on autophagosomes Starvation-dependent trafficking requires ULK1, ATG13 and SUPT20H |
| Tissue Specificity | This ATG9A antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 598~628 amino acids surrounding S613 of human APG9L1. |
| Cellular Localization | Cytoplasmic vesicle, autophagosome membrane; Multi-pass membrane protein (By similarity). Golgi apparatus, trans-Golgi network membrane; Multi-pass membrane protein. Late endosome membrane; Multi-pass membrane protein |
| Entrez Gene | 79065 |
|---|
Application
Fluorescent image of U251 cells stained with ATG9A antibody. U251 cells were treated with Chloroquine (50 μM,16h), then fixed with 4% PFA (20 min), permeabilized with Triton X-100 (0.2%, 30 min). Cells were then incubated with AP1814e ATG9A primary antibody (1:100, 2 h at room temperature). For secondary antibody, Alexa Fluor® 488 conjugated donkey anti-rabbit antibody (green) was used (1:1000, 1h). Cytoplasmic actin was counterstained with Alexa Fluor® 555 (red) conjugated Phalloidin (5.25 μM, 25 min). Nuclei were counterstained with Hoechst 33342 (blue) (10 μg/ml, 5 min). Pictures were taken on a Biorevo microscope (BZ-900, Keyence).ATG9A immunoreactivity is localized to autophagic vacuoles in the cytoplasm of U251 cells.
Application
"Western blot analysis of APG9L1 (arrow) using rabbit polyclonal APG9L1 Antibody (S613) (Cat.#1814e).293 cell lysates (2 ug/lane) either nontransfected (Lane 1) or transiently transfected with the APG9L1 gene (Lane 2) (Origene Technologies)."
Application
Formalin-fixed and paraffin-embedded human lung carcinoma tissue reacted with APG9L1 Antibody (S613) , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. This data demonstrates the use of this antibody for immunohistochemistry; clinical relevance has not been evaluated.| Application Notes | IF:1:100 WB |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
